CYP2C9 Cancer Research Results
CYP2C9, CYP2C9: Click to Expand ⟱
| Source: |
| Type: |
CYP2C9, cytochrome P450 enzyme
– CYP2C9 is involved in the metabolism of a range of xenobiotics, including several anticancer drugs, which can affect drug efficacy and toxicity.
– Although CYP2C9 is not traditionally considered an oncogene or tumor suppressor, its expression and genetic variants can influence patient responses to chemotherapy.
|
Scientific Papers found: Click to Expand⟱
*CYP1A1↓, *CYP2C19↓, *CYP2C8↓, *CYP2C9↓, *CYP3A4↓, *CYP2E1↓, *CYP2D6↓, *BioEnh↑, eff↑,
*Inflam↓, *antiOx↓, *hepatoP↓, *TC↓, *CYP2C9↓, *CYP2C19↓, *other↝,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Total Targets: 1
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioEnh↑, 1, CYP1A1↓, 1, CYP2C19↓, 2, CYP2C8↓, 1, CYP2C9↓, 2, CYP2D6↓, 1, CYP2E1↓, 1, CYP3A4↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
TC↓, 1,
Functional Outcomes(tgid=23) ⓘ
hepatoP↓, 1,
Total Targets: 13
Scientific Paper Hit Count for: CYP2C9, CYP2C9
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1130 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page